Volume 9, Issue 9, Pages (September 2008)

Slides:

Advertisements

Similar presentations

Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys Prof Deborah S.

Advertisements

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Fever of unknown origin and cancer: a population-based study

Volume 390, Issue 10098, Pages (September 2017)

Volume 367, Issue 9517, Pages (April 2006)

Volume 6, Issue 7, Pages (July 2005)

Volume 357, Issue 9257, Pages (March 2001)

Pharmacogenetics and future drug development and delivery

Volume 349, Issue 9057, Pages (April 1997)

Volume 387, Issue 10021, Pages (February 2016)

Volume 11, Issue 4, Pages (April 2012)

Volume 16, Issue 9, Pages (September 2015)

Thank God for Richard Dawkins?

Long-term effects of hormone replacement therapy

Effectiveness of Canada's tuberculosis surveillance strategy in identifying immigrants at risk of developing and transmitting tuberculosis: a population-based.

Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial

Volume 5, Issue 4, Pages (April 2006)

Volume 13, Issue 12, Pages (December 2012)

Volume 15, Issue 10, Pages (September 2014)

Volume 9, Issue 12, Pages (December 2008)

Volume 9, Issue 5, Pages (May 2008)

Volume 13, Issue 3, Pages (March 2012)

Long-term effects of hormone replacement therapy

Volume 366, Issue 9486, Pages (August 2005)

Hormones and bones The Lancet Volume 349, Pages S20-S23 (March 1997)

Aspirin in the prevention of cancer – Author's reply

Volume 14, Issue 10, Pages (September 2013)

Volume 9, Issue 9, Pages (September 2008)

Volume 15, Issue 4, Pages (April 2014)

Gene therapy in haematology and oncology

Volume 372, Issue 9642, Pages (September 2008)

Volume 365, Issue 9466, Pages (April 2005)

Physiological hazards of flight at high altitude

Volume 9, Issue 10, Pages (October 2008)

Volume 379, Issue 9835, Pages (June 2012)

Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study Sune F Nielsen, PhD, Prof Børge G Nordestgaard,

An update on Zika virus infection

Volume 375, Issue 9732, Pages (June 2010)

Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study Jue Liu, PhD, Shikun Zhang, MD,

Volume 13, Issue 12, Pages (December 2012)

The mystery of addiction

Cold water immersion: sudden death and prolonged survival

What would happen if we stopped vaccination?

Volume 11, Issue 4, Pages (April 2010)

Confessions of a journal junkie

Volume 379, Issue 9812, Pages (January 2012)

Volume 372, Issue 9647, Pages (October 2008)

Volume 387, Issue 10021, Pages (February 2016)

Telling it like it isn't: truth and lies in a post-9/11 world

Volume 9, Issue 4, Pages (April 2008)

Volume 383, Issue 9922, Pages (March 2014)

Volume 377, Issue 9771, Pages (March 2011)

Volume 15, Issue 13, Pages (December 2014)

Volume 5, Issue 4, Pages (April 2018)

Volume 375, Issue 9726, Pages (May 2010)

Thank God for Richard Dawkins?

Prof GJB van Ommen, PhD, E Bakker, PhD, JT den Dunnen, PhD The Lancet

Volume 7, Issue 8, Pages (August 2008)

Volume 381, Issue 9880, Pages (May 2013)

ACST: which subgroups will benefit most from carotid endarterectomy?

Volume 11, Issue 3, Pages (March 2010)

Volume 11, Issue 1, Pages (January 2010)

Volume 376, Issue 9734, Pages (July 2010)

Arlene Chan, Marc Buyse, Bin Yao The Lancet Oncology

Costs of eliminating HIV in South Africa have been underestimated

Volume 372, Issue 9632, Pages (July 2008)

Volume 12, Issue 1, Pages (January 2011)

A remarkable report card on progress in COPD

Refining treatment choices for ADHD

Autism, maths, and sex: the special triangle

Presentation transcript:

Volume 9, Issue 9, Pages 866-872 (September 2008) Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis Ivana Sestak, PhD, Prof Jack Cuzick, PhD, Francisco Sapunar, MD, Prof Richard Eastell, MD, Prof John F Forbes, FRACS, Angelo R Bianco, MD, Aman U Buzdar, MD The Lancet Oncology Volume 9, Issue 9, Pages 866-872 (September 2008) DOI: 10.1016/S1470-2045(08)70182-7 Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 1 Patients (%) developing joint symptoms at or before a specified follow-up time during active treatment according to treatment first received in women without joint symptoms at entry (study population) The Lancet Oncology 2008 9, 866-872DOI: (10.1016/S1470-2045(08)70182-7) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 2 Smoothed annual hazard rates (%) of newly reported joint symptoms during active treatment according to treatment first received in women without joint symptoms at entry (study population) The Lancet Oncology 2008 9, 866-872DOI: (10.1016/S1470-2045(08)70182-7) Copyright © 2008 Elsevier Ltd Terms and Conditions